As of 2025-07-02, the Relative Valuation of Antibe Therapeutics Inc (ATE.TO) is (8.24) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 CAD, the upside of Antibe Therapeutics Inc based on Relative Valuation is -2894.7%.
The range of the Relative Valuation is (6.60) - (9.89) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 27.9x | 23.2x |
| Forward P/E multiples | 18.6x - 27.9x | 23.2x |
| Fair Price | (6.60) - (9.89) | (8.24) |
| Upside | -2335.8% - -3453.6% | -2894.7% |
| Date | P/E |